Search Results 1301-1310 of 21422 for anti-TNF drugs

1. Guanfacine (Oral Route) Proper Use - Mayo Clinic

   Take your daily dose of guanfacine at bedtime. · In addition to the use of the medicine your doctor has prescribed, treatment for your high blood pressure may ...

2. Leuprolide And Norethindrone (Intramuscular Route, Oral Route) Before Using - Mayo Clinic

   An alternative to this medication should be prescribed or you should stop breastfeeding while using this medicine. Drug Interactions. Although certain medicines ...

3. A Study to Evaluate Effectiveness and Safety of Ustekinumab Re-induction Therapy in Participants With Moderate to Severely Active Crohn's Disease (POWER) - Mayo Clinic

   A Study to Evaluate Effectiveness and Safety of Ustekinumab Re-induction Therapy in Participants With Moderate to Severely Active Crohn's Disease (POWER). Print ...

4. Eflapegrastim-Xnst (Subcutaneous Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

5. Despite Claims, Synthetic Growth Hormone Not Effective as Anti-aging Treatment - Mayo Clinic News Network

   ... treatment for some medical conditions. However, it is not intended to be used as an anti-aging medication. No evidence exists that shows HGH works against ...

6. Pentazocine And Naloxone (Oral Route) Description and Brand Names - Mayo Clinic

   Pentazocine and naloxone combination is used to relieve pain severe enough to require opioid treatment and when other pain medicines did not work well enough or ...

7. Monoctanoin (Injection Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

8. A Study to Assess the Effectiveness and Safety of Apremilast in Pediatric Patients (6 through 17 years old) with Moderate-to-Severe Plaque Psoriasis - Mayo Clinic

   Etanercept (or biosimilar) treatment four weeks prior to randomization;; Adalimumab (or biosimilar) treatment ten weeks prior to randomization;; Other TNF or ...

9. Fam-Trastuzumab Deruxtecan-Nxki (Intravenous Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

10. Advances in lung cancer immunotherapy and management of immune-mediated adverse events - Mayo Clinic

    Monotherapy, using the anti-PD-1 antibody pembrolizumab, is now Food and Drug Administration (FDA) approved for patients with stage IV non-small cell lung ...